| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $2,705,648 ) |
| | 2026 | 2026 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK143607 | Epigenetic basis of physiology and pathophysiology of glucocorticoids action on pancreatic beta cells | 000 | 1 | NIH | 1/22/2026 | $807,446 |
| | 2026 | 2026 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01EB293388 | Online Adaptive Proton Therapy | 000 | 2 | NIH | 12/11/2025 | $511,016 |
| | 2026 | 2026 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL162747 | Strategies to Enhance Engineered Heart Tissue Based Myocardial Repair | 000 | 4 | NIH | 2/16/2026 | $688,315 |
| | 2026 | 2026 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA271431 | STAT5/OLIG2 regulation of GBM therapeutic resistance and recurrence - Resubmit 3.22 | 000 | 4 | NIH | 1/8/2026 | $535,257 |
| | 2026 | 2026 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K08DK134759 | Aging lymphocytes: senescence programs in lymphocytes relevant to human inflammatory bowel disease | 000 | 4 | NIH | 12/19/2025 | $163,614 |
| | 2026 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U01CA269264 | Flexible NLP toolkit for automatic curation of outcomes for breast cancer patients | 000 | 4 | NIH | 2/10/2026 | $0 |
| | 2026 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL133501 | Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure | 000 | 7 | NIH | 10/24/2025 | $0 |
| | 2026 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01GM141003 | Impact of membrane composition on cholecystokinin receptor structure and function | 000 | 4 | NIH | 10/20/2025 | $0 |
| | 2026 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U1355158 | Living Organ Donation Reimbursement Program (LODRP) | 05 | 1 | HRSA | 12/9/2025 | $0 |
| | 2026 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U1355158 | Living Organ Donation Reimbursement Program (LODRP) | 04 | 1 | HRSA | 11/18/2025 | $0 |
| | 2026 | 2022 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01FD006102 | A Prospective, Randomized, Multi-centered, Placebo-controlled Clinical Trial of Oral Vancomycin in Adults with Primary Sclerosing Cholangitis | 000 | 4 | FDA | 1/29/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $34,410,911 ) (Continued on the next page) |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K01NS124911 | Feasibility, Acceptability, and Pilot Testing of a Behavioral Intervention for Chronic Migraine | 001 | 5 | NIH | 8/18/2025 | $240,354 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | F32CA294616 | Elucidating the functional role of KLRG1+ conventional helper T cells in the tumor microenvironment | 001 | 1 | NIH | 6/25/2025 | $0 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | F32CA294616 | Elucidating the functional role of KLRG1+ conventional helper T cells in the tumor microenvironment | 000 | 1 | NIH | 6/25/2025 | $78,040 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AI089714 | Inflammatory cascades disrupt Treg function through epigenetic mechanisms | 002 | 16 | NIH | 5/19/2025 | $505,712 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL133501 | Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure | 001 | 7 | NIH | 8/12/2025 | $45,463 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL133501 | Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure | 000 | 7 | NIH | 11/11/2024 | $409,169 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA289249 | Multimodal AI Fusion Model for Early Detection for Pancreatic Cancer | 001 | 2 | NIH | 8/20/2025 | $566,529 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K08DK134759 | Aging lymphocytes: senescence programs in lymphocytes relevant to human inflammatory bowel disease | 001 | 3 | NIH | 12/10/2024 | $163,614 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL167811 | Opportunistic Screening for ASCVD using a Multimodal Deep Learning Risk Prediction Model | 001 | 2 | NIH | 4/7/2025 | $0 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL167811 | Opportunistic Screening for ASCVD using a Multimodal Deep Learning Risk Prediction Model | 002 | 2 | NIH | 8/19/2025 | $68,378 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL167811 | Opportunistic Screening for ASCVD using a Multimodal Deep Learning Risk Prediction Model | 000 | 2 | NIH | 11/22/2024 | $615,394 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R35GM155031 | Engineering cell-based therapy for enhanced survival and durable function in vivo | 000 | 2 | NIH | 5/23/2025 | $416,250 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K76AG088554 | Genetic architecture of age of onset of amyloid positivity: Integrating imaging and genetic tools to identify novel drivers of disease | 004 | 3 | NIH | 6/26/2025 | $243,000 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R21AI182888 | Pulmonary Response to Ozone-exposed Ragweed Pollen Grains | 000 | 2 | NIH | 4/16/2025 | $196,080 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01NR021634 | Pulmonary Rehabilitation for Rural Patients with COPD | 001 | 2 | NIH | 7/23/2025 | $784,990 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL161674 | Gender and Asthma | 000 | 3 | NIH | 12/5/2024 | $363,443 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01GM141003 | Impact of membrane composition on cholecystokinin receptor structure and function | 001 | 4 | NIH | 9/9/2025 | $461,634 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01GM141003 | Impact of membrane composition on cholecystokinin receptor structure and function | 000 | 4 | NIH | 12/23/2024 | $415,470 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK130566 | Healing enterocutaneous fistulas using bioengineered biomaterials | 000 | 4 | NIH | 11/18/2024 | $511,541 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01GM141003 | Impact of membrane composition on cholecystokinin receptor structure and function | 001 | 4 | NIH | 9/9/2025 | -$415,470 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R37CA276047 | Targeting PP4 to improve ovarian cancer response to immunotherapy | 000 | 3 | NIH | 7/23/2025 | $457,776 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AA031257 | Biomarkers and pathogenesis of Alcoholic acute pancreatitis | 001 | 2 | NIH | 8/19/2025 | $57,549 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AA031257 | Biomarkers and pathogenesis of Alcoholic acute pancreatitis | 000 | 2 | NIH | 12/9/2024 | $517,938 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA272426 | preclinical optimization of BCMA directed T cell therapy | 000 | 3 | NIH | 8/15/2025 | $621,878 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AI169530 | Allergen-induced extracellular DNA in type 2 immunity | 001 | 4 | NIH | 8/21/2025 | $1,247,804 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL165176 | Biomaterials for embolization and ablation of arterio-venous malformations | 000 | 4 | NIH | 8/22/2025 | $608,052 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AG080037 | The role of lymph node structural organization in naïve T cell decline with age | 000 | 3 | NIH | 4/11/2025 | $532,385 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AG080037 | The role of lymph node structural organization in naïve T cell decline with age | 002 | 3 | NIH | 6/18/2025 | $47,324 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U01CA269264 | Flexible NLP toolkit for automatic curation of outcomes for breast cancer patients | 001 | 4 | NIH | 8/1/2025 | $332,408 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AI170649 | Control of antiviral memory CD8+ T cell longevity by extracellular ATP sensing | 000 | 4 | NIH | 6/23/2025 | $473,714 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01NS127922 | Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma | 001 | 3 | NIH | 5/29/2025 | $439,965 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA257558 | Drug eluting injectable biomaterials for next generation chemoembolization | 000 | 5 | NIH | 7/11/2025 | $617,904 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA264048 | Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen | 000 | 5 | NIH | 9/11/2025 | $606,007 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K23AI158813 | Mechanisms of adverse gastrointestinal events during oral immunotherapy | 000 | 4 | NIH | 7/7/2025 | $189,864 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL156855 | Cardiomyocyte Non-autonomous Factors and Cardiac Regeneration in Large Mammals | 000 | 4 | NIH | 6/30/2025 | $668,014 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | F31AI186242 | Assessing food-specific tolerogenic CD4+ T cells in protection from food allergy | 000 | 1 | NIH | 5/1/2025 | $48,974 |
| | 2025 | 2025 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | F31AI186242 | Assessing food-specific tolerogenic CD4+ T cells in protection from food allergy | 003 | 1 | NIH | 8/4/2025 | $564 |
|
